Klamath Blue-Green Algae (Aphanizomenon flos-aquae)

What Is Klamath Blue-Green Algae?

Klamath Blue-Green Algae is catalogued in the Materia Medica under the binomial Aphanizomenon flos-aquae, a alga of the Nostocaceae family, native to freshwater lakes of the Northern Hemisphere. The material in circulation is whole cyanobacterium — the whole plant, used without separating the parts. The common name Klamath Blue-Green Algae and the botanical name Aphanizomenon flos-aquae refer to the same material, and labels may use either — a detail that matters when related species in the same genus are not interchangeable. In the hand it reads as deep marine, mineral, grassy — a practical marker of freshness and correct identification.

The written history of Klamath Blue-Green Algae begins with household and practitioner use — recipes, harvesting notes and cautions passed between regions — and only much later with laboratory description of what the whole cyanobacterium contains. Beyond its practical use it carries cultural associations — klamath tribe ancestral lake food.

Today most searches for Klamath Blue-Green Algae come from people reading about anti aging and colds & flu, or checking how it sits alongside a medication they already take. The use most often documented in the literature is neurotrophic — improves attention in preliminary trials, followed by antioxidant phycocyanin.

How Does Klamath Blue-Green Algae Work?

Klamath Blue-Green Algae works as a mixture rather than a single isolated compound, and its profile is usually described by the class of constituents present in whole cyanobacterium rather than by one marker molecule.

Traditional practice described Klamath Blue-Green Algae in terms of taste, warmth and preparation rather than molecules — a working vocabulary that predicted which extractions were worth making long before any compound was isolated.

Published research is limited, leaning on small trials, laboratory work and animal models, and this profile cites 1 source. Reported findings centre on contains phycocyanin, PEA, chlorophyll, β-carotene. Where research exists, it examines neurotrophic — improves attention in preliminary trials, antioxidant phycocyanin and PEA content of interest for mood support. These are areas of study, not established outcomes, and results differ by preparation and dose.

How the plant is prepared changes what you actually get. Its constituents move readily into water and alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.

The reason Klamath Blue-Green Algae is treated as its own entry rather than a substitute for a related plant is proportion: related species share several of these compound classes, but not in the same ratio or concentration.

Because these constituents are processed by the same pathways that handle many medicines, Klamath Blue-Green Algae is documented as interacting with maois. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.

Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Klamath Blue-Green Algae can differ substantially; this is why reference entries specify whole cyanobacterium and, where they exist, standardisation markers.

Browse all 1000+ botanicals in the Materia Medica